Cargando…

Exploring the Impact of Modifiable Factors on Serum BDNF in Psychiatric Patients and Community Controls

BACKGROUND: Brain-derived neurotrophic factor (BDNF) has been a focus of psychiatric research for the past two decades. BDNF has been shown to impact neural function and development. Studies have investigated serum BDNF as a biomarker for psychiatric disorders such as depression and schizophrenia. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Galen, Rosic, Tea, Pasyk, Stanislav, Dehghan, Mahshid, Samaan, Zainab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898784/ https://www.ncbi.nlm.nih.gov/pubmed/33628025 http://dx.doi.org/10.2147/NDT.S295026

Ejemplares similares

Evaluation of BDNF as a Biomarker for Impulsivity in a Psychiatric Population
por: Pasyk, Stanislav, et al.
Publicado: (2020)

Virtual psychiatric care fast-tracked: reflections inspired by the COVID-19 pandemic
por: Rosic, Tea, et al.
Publicado: (2020)

Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities
por: Chu, Robert Karoly, et al.
Publicado: (2017)

Exploring the Association between Serum BDNF and Attempted Suicide
por: Eisen, Rebecca B., et al.
Publicado: (2016)

Sensitivity and specificity of self-reported psychiatric diagnoses amongst patients treated for opioid use disorder
por: Leung, Kelly, et al.
Publicado: (2021)

Exploring psychological symptoms and associated factors in patients receiving medication-assisted treatment for opioid-use disorder
por: Rosic, Tea, et al.
Publicado: (2020)

The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study
por: Rosic, Tea, et al.
Publicado: (2017)

Psychosis and Comorbid Opioid Use Disorder: Characteristics and Outcomes in Opioid Substitution Therapy
por: Lamont, Rachel, et al.
Publicado: (2020)

The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences
por: Naji, Leen, et al.
Publicado: (2018)

Children and Youth Who Use Cannabis for Pain Relief: Benefits, Risks, and Perceptions
por: Woo, Julia J, et al.
Publicado: (2020)

Trauma and post-traumatic stress disorder in patients treated for opioid use disorder: findings from a 12-month cohort study
por: Rosic, Tea, et al.
Publicado: (2021)

The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder
por: Naji, Leen, et al.
Publicado: (2021)

Profile of suicide attempts and risk factors among psychiatric patients: A case-control study
por: Bhatt, Meha, et al.
Publicado: (2018)

Association between vaping and health outcomes in patients with opioid use disorder: a systematic review protocol
por: Sanger, Nitika, et al.
Publicado: (2021)

Impact of COVID-19 and other pandemics and epidemics on people with pre-existing mental disorders: a systematic review protocol and suggestions for clinical care
por: Sergeant, Anjali, et al.
Publicado: (2020)

Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?
por: Au, Vivian Y. O., et al.
Publicado: (2021)

Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder
por: van Reekum, Emma A., et al.
Publicado: (2020)

Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada
por: Rosic, Tea, et al.
Publicado: (2021)

Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review
por: van Reekum, Emma A., et al.
Publicado: (2021)

Association between BDNF levels and suicidal behaviour: a systematic review protocol
por: Eisen, Rebecca, et al.
Publicado: (2015)

Association between BDNF levels and suicidal behaviour: a systematic review and meta-analysis
por: Eisen, Rebecca B., et al.
Publicado: (2015)

The Inclusion of Patients’ Reported Outcomes to Inform Treatment Effectiveness Measures in Opioid Use Disorder. A Systematic Review
por: Sanger, Nitika, et al.
Publicado: (2022)

Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder
por: Chai, Darren, et al.
Publicado: (2021)

The association between cannabis use and outcome in pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data
por: Naji, Leen, et al.
Publicado: (2022)

The Role of Perceived Social Support in the Association Between Stressful Life Events and Suicidal Behavior
por: Panesar, Balpreet, et al.
Publicado: (2021)

Are patients’ goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder
por: Rosic, Tea, et al.
Publicado: (2021)

A Scoping Review on Barriers to Mental Healthcare in Canada as Identified by Healthcare Providers
por: Wang, Jeffrey, et al.
Publicado: (2022)

Untangling the Conformational Plasticity of V66M Human proBDNF Polymorphism as a Modifier of Psychiatric Disorder Susceptibility
por: Covaceuszach, Sonia, et al.
Publicado: (2022)

The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials
por: Sanger, Nitika, et al.
Publicado: (2020)

Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain–liver axis
por: Yang, B, et al.
Publicado: (2017)

Modifying effect of the serum level of brain-derived neurotrophic factor (BDNF) on the association between BDNF methylation and long-term cardiovascular outcomes in patients with acute coronary syndrome
por: Choi, Wonsuk, et al.
Publicado: (2023)

BDNF, proBDNF and IGF-1 serum levels in naïve and medicated subjects with autism
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2022)

Cerebellar BDNF Promotes Exploration and Seeking for Novelty
por: Laricchiuta, Daniela, et al.
Publicado: (2018)

Impact of BDNF Val66Met Polymorphism on Myocardial Infarction: Exploring the Macrophage Phenotype
por: Sandrini, Leonardo, et al.
Publicado: (2020)

Serum BDNF Levels Are Reduced in Patients with Disorders of Consciousness and Are Not Modified by Verticalization with Robot-Assisted Lower-Limb Training
por: Bagnato, Sergio, et al.
Publicado: (2020)

Serum mBDNF and ProBDNF Expression Levels as Diagnosis Clue for Early Stage Parkinson's Disease
por: Yi, Xu, et al.
Publicado: (2021)

Re-Examination of Classic Risk Factors for Suicidal Behavior in the Psychiatric Population
por: Dennis, Brittany B., et al.
Publicado: (2015)

Comparison of the serum brain-derived neurotrophic factor (BDNF) between fibromyalgia and nociceptive pain groups; and effect of duloxetine on the BDNF level
por: Bidari, Ali, et al.
Publicado: (2022)

Serum brain-derived neurotrophic factor (BDNF) is not regulated by testosterone in transmen
por: Auer, Matthias K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_50pov60hnt61ru0stf8sh65hko